Gastrointestinal stromal tumour – metastatic or unresectable Initial PBS authority application Supporting information form (PB095)

You must lodge this form for a patient starting initial PBS subsidised treatment with imatinib mesylate for metastatic or unresectable malignant gastrointestinal stromal tumour.

 

Page last updated: 13 July 2016

This information was printed Friday 30 September 2016 from humanservices.gov.au/health-professionals/forms/pb095 It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.